Novogene Co., Ltd. (SHA:688315)

Novogene Revenue

Novogene had revenue of 556.43M CNY in the quarter ending March 31, 2026, with 10.84% growth. This brings the company's revenue in the last twelve months to 2.26B, up 5.56% year-over-year. In the year 2025, Novogene had annual revenue of 2.21B with 4.66% growth.

• Revenue (ttm): 2.26B
• Revenue Growth: +5.56%
• P/S Ratio: 2.86
• Revenue / Employee: 1.02M
• Employees: 2,190
• Market Cap: 6.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.21B	98.32M	4.66%
Dec 31, 2024	2.11B	109.21M	5.45%
Dec 31, 2023	2.00B	76.47M	3.97%
Dec 31, 2022	1.93B	59.24M	3.17%
Dec 31, 2021	1.87B	376.37M	25.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error